Haloperidol-d4 N-Oxide

• CAT Number: R047406
• CAS Number: 1246815-56-4
• Molecular Formula: C21H23ClFNO3
• Molecular Weight: 395.892
• Purity: ≥95%
• Synonyms: 4-[4-(4-Chlorophenyl-d4)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone; 4-[4-(4-Chlorophenyl-d4)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone N-Oxide
• Storage: -20°C
• IUPAC Name: 4-[4-(4-chloro-2,3,5,6-tetradeuteriophenyl)-4-hydroxy-1-oxidopiperidin-1-ium-1-yl]-1-(4-fluorophenyl)butan-1-one
• InChI: InChI=1S/C21H23ClFNO3/c22-18-7-5-17(6-8-18)21(26)11-14-24(27,15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2/i5D,6D,7D,8D
• InChIKey: LDKZFGVWYVWUSG-KDWZCNHSSA-N
• SMILES: [2H]C1=C(C(=C(C(=C1C2(CC[N+](CC2)(CCCC(=O)C3=CC=C(C=C3)F)[O-])O)[2H])[2H])Cl)[2H]

Haloperidol-d4 N-Oxide is a deuterated form of haloperidol N-oxide, featuring four deuterium atoms. This compound is used primarily in pharmaceutical and biochemical research to enhance the precision of analytical techniques such as NMR and mass spectrometry. Haloperidol N-oxide, an oxidative metabolite of haloperidol, is important for studying the metabolism and pharmacokinetics of this antipsychotic drug. The deuterium labeling allows for detailed investigations into the drug’s metabolic pathways, interactions, and stability. It is valuable for optimizing therapeutic strategies and understanding the pharmacological behavior of haloperidol and its metabolites in various biological systems.